Summary

Eligibility
for people ages 45 years and up (full criteria)
Location
at UC Davis
Dates
study started
completion around

Description

Summary

The HIP ATTACK-2 trial is a multicentre, international, parallel group randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute myocardial injury is superior to standard care in reducing death at 90 days after randomization. The trial will also assess secondary outcomes at 90 days after randomization: inability to independently walk 3 metres, time to first mobilization (first standing and first full weight bear), composite and individual assessment of major complications (e.g., mortality, non-fatal myocardial infarction, acute congestive heart failure, and stroke), delirium, length of stay, pain, and quality of life.

Official Title

HIP Fracture Accelerated Surgical TreaTment and Care TracK 2 (HIP ATTACK-2) Trial

Keywords

Hip Fractures, Myocardial Injury, Bone Fractures, Accelerated medical clearance and surgery

Eligibility

Locations

  • The Regents of the University of California accepting new patients
    Davis California 95618 United States
  • Christus Muguerza del Parque accepting new patients
    Chihuahua 31000 Mexico

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Population Health Research Institute
ID
NCT04743765
Study Type
Interventional
Participants
Expecting 1100 study participants
Last Updated